| 摘要 |
The present invention concerns oral dosage forms of some particular salts of (+)- or (-)-cisapride, more particularly (+)- or (-)-cisapride-(L)-tartrate, (+)- or (-)-cisapride-(D)-tartrate, (+)- or (-)-cisapride-sulfate, or (+)- or (-)-cisapride citrate, which avoid drug-food interaction and which allow comedication of agents that increase the pH of the stomach. The invention particularly relates to solid oral dosage forms suitable for rapid dissolution. The present invention also concerns tablets which can be prepared via direct compression. |
